To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.
This study has been completed.
Information provided by:
First received: September 6, 2005
Last updated: December 28, 2006
Last verified: December 2006
To evaluate the safety and efficacy of pregabalin in patients with painful diabetic peripheral neuropathy.
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||An Open-Label, Extension Safety and Efficacy Study of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Pfizer:
Contacts and Locations